Echo Therapeutics Inc fka ECTE

[seeker_of_value]

2013 is the year where ECTE should have its day. Early in 2013 Europe will clarify if they need a trial and if so how big the trial will need to be. Their expected trial size is between 0 and 50. If Europe agrees to accept the methodology based on previous trial data it will be a big boost to the stock. US will probably need a trial and is always more rigorous in device approvals. However, US approval is also currently projected in 2013. The issue with such companies is always money. They need several million dollars every quarter. So if Europe approval does not happen quickly, they may need to sell some more shares in the market which will drop the price even further. Take a look at ECTE long term chart, $1 is a very strong 3 year support. It should hold. I got into ECTE recently, so have not understood why the company is selling shares to public instead of drawing money from Montaur Platinum.

For further information please look at this report:

http://lifetechcapital.com/ltc/wp-content/uploads/2012/12/Morning-Note-12-05-12-ECTE.pdf